The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
1 Year | 5 Year | 5 Year Annualized | Since IPO | |
---|---|---|---|---|
SMMNY | +1.92% | +35.53% | +6.27% | +49% |
S&P | +15.06% | +95.03% | +14.29% | +147% |
Siemens Healthineers AG operates as a holding company. The company intends to operate the digital services business. It operates through the following business segments: Imaging, Diagnotics, and Advanced Therapies. The Imaging segment offers diagnostic imaging products and a broad portfolio of advanced imaging and ultrasound systems and solutions. The Diagnostics segment offers products, services and solutions, including a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Advanced Therapies is a supplier of advanced therapy products, services and solutions to the therapy departments of healthcare providers. The company was founded on December 1, 2017 and is headquartered in Erlangen, Germany.
Q2 2025 | YOY Change | |
---|---|---|
Revenue | $6.42B | 10.0% |
Gross Profit | $2.47B | 10.0% |
Gross Margin | 38.52% | 0.0% |
Market Cap | $62.22B | -3.0% |
Market Cap / Employee | $0.85M | -5.2% |
Employees | 73.5K | 2.4% |
Net Income | $630.69M | 24.1% |
EBITDA | $1.41B | 33.1% |
Currently no data to display
Currently no data to display.
Currently no data to display.
Q2 2025 | YOY Change | |
---|---|---|
Net Cash | $2.79B | 26.5% |
Accounts Receivable | $7.15B | 11.3% |
Inventory | 5.2K | 2.0% |
Q2 2025 | YOY Change | |
---|---|---|
Long Term Debt | $13.68B | -11.5% |
Short Term Debt | $4.75B | 81.7% |
Q2 2025 | YOY Change | |
---|---|---|
Return On Assets | 4.63% | 0.6% |
Return On Invested Capital | 6.50% | -1.1% |
Q2 2025 | YOY Change | |
---|---|---|
Free Cash Flow | $836.22M | 54.0% |
Operating Free Cash Flow | $1.05B | 41.4% |
Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
---|---|---|---|---|---|
Price to Earnings | 31.89 | 27.60 | 26.73 | 26.19 | -18.15% |
Price to Book | 3.43 | 2.90 | 2.93 | 3.09 | -3.18% |
Price to Sales | 2.78 | 2.44 | 2.43 | 2.45 | -9.39% |
Price to Tangible Book Value | -8.75 | -8.09 | -9.54 | -8.87 | 0.19% |
Price to Free Cash Flow TTM | 87.78 | 42.74 | 236.16 | 37.05 | -92.32% |
Enterprise Value to EBITDA | 47.43 | 67.17 | 59.90 | 55.31 | -27.21% |
Free Cash Flow Yield | 1.1% | 2.3% | 0.4% | 2.7% | 1202.58% |
Return on Equity | 10.7% | 10.7% | 11.1% | 11.8% | 11.66% |
Total Debt | $18.09B | $17.21B | $18.21B | $18.43B | 1.98% |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.